Le Lézard
Classified in: Health
Subjects: RCL, CFG

Food Recall Warning - UNREAL brand dark chocolate coconut minis recalled due to Salmonella


Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/unreal-brand-dark-chocolate-coconut-minis-recalled-due-salmonella

OTTAWA, ON, Oct. 21, 2022 /CNW/ - 

Summary

Affected products

Brand

Product

Size

UPC

Codes

UNREAL

dark chocolate coconut minis

435 g

8 57484 00688 8

 

ITM./ART. 1268728

Best Before

23AU04

23AU05

23AU31

23SE01

23SE02

23SE09

23SE16

23SE19

23SE20

23SE21

23SE22

23SE23

23SE26

23SE27

23SE28

23SE29

23SE30

23OC03

 

Issue

The affected product is being recalled from the marketplace due to possible Salmonella contamination.

The recalled product has been sold in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, and Newfoundland and Labrador.

What you should do

Food contaminated with Salmonella may not look or smell spoiled but can still make you sick. Young children, pregnant women, the elderly and people with weakened immune systems may contract serious and sometimes deadly infections. Healthy people may experience short-term symptoms such as fever, headache, vomiting, nausea, abdominal cramps and diarrhea. Long-term complications may include severe arthritis.

Learn more:

Background

This recall was triggered by the company.

There have been no reported illnesses associated with the consumption of this product.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.

The CFIA is verifying that industry is removing recalled products from the marketplace.

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: